Matches in Wikidata for { <http://www.wikidata.org/entity/Q66071389> ?p ?o ?g. }
Showing items 1 to 33 of
33
with 100 items per page.
- Q66071389 description "clinical trial" @default.
- Q66071389 description "ensayu clínicu" @default.
- Q66071389 description "klinisch onderzoek" @default.
- Q66071389 description "клінічне випробування" @default.
- Q66071389 name "ADVANCE Study of DTG + TAF + FTC vs DTG + TDF + FTC and EFV + TDF+FTC in First-line Antiretroviral Therapy" @default.
- Q66071389 name "ADVANCE Study of DTG + TAF + FTC vs DTG + TDF + FTC and EFV + TDF+FTC in First-line Antiretroviral Therapy" @default.
- Q66071389 type Item @default.
- Q66071389 label "ADVANCE Study of DTG + TAF + FTC vs DTG + TDF + FTC and EFV + TDF+FTC in First-line Antiretroviral Therapy" @default.
- Q66071389 label "ADVANCE Study of DTG + TAF + FTC vs DTG + TDF + FTC and EFV + TDF+FTC in First-line Antiretroviral Therapy" @default.
- Q66071389 prefLabel "ADVANCE Study of DTG + TAF + FTC vs DTG + TDF + FTC and EFV + TDF+FTC in First-line Antiretroviral Therapy" @default.
- Q66071389 prefLabel "ADVANCE Study of DTG + TAF + FTC vs DTG + TDF + FTC and EFV + TDF+FTC in First-line Antiretroviral Therapy" @default.
- Q66071389 P1132 Q66071389-EF01BD9A-DF93-48CB-9BD5-3F03DF059517 @default.
- Q66071389 P1476 Q66071389-63393EDB-5019-4ABF-B771-4DA5A22A3C3E @default.
- Q66071389 P17 Q66071389-D81A17A1-EEFC-4A06-B1F0-A6D93C24B075 @default.
- Q66071389 P1813 Q66071389-67229C54-301D-466F-B881-8B89ECA134E9 @default.
- Q66071389 P2899 Q66071389-FF9E8A64-3491-4795-94A2-9E66F25FC06F @default.
- Q66071389 P3098 Q66071389-A4427538-A41B-42D9-9E5B-99F4A5E4002F @default.
- Q66071389 P31 Q66071389-BB80A197-90C3-4805-8F56-7ED6A9CC5DDD @default.
- Q66071389 P580 Q66071389-47B61B91-635C-4F9E-80E0-1A7244F84AA0 @default.
- Q66071389 P582 Q66071389-3AB13FDC-9C14-4065-9D1C-A3146A5E3910 @default.
- Q66071389 P6099 Q66071389-065D60E0-A62A-42A6-9D10-21449AA6E87A @default.
- Q66071389 P8363 Q66071389-7E2C0D70-9320-4DC4-A888-3FF31652E44D @default.
- Q66071389 P1132 "+1110" @default.
- Q66071389 P1476 "A 96-week Randomised, Phase 3 Non-inferiority Study of DTG + TAF + FTC Compared With DTG + TDF + FTC and EFV + TDF+FTC in Patients Infected With HIV-1 Starting First-line Antiretroviral Therapy" @default.
- Q66071389 P17 Q258 @default.
- Q66071389 P1813 "ADVANCE" @default.
- Q66071389 P2899 "+12" @default.
- Q66071389 P3098 "NCT03122262" @default.
- Q66071389 P31 Q30612 @default.
- Q66071389 P580 "2017-01-16T00:00:00Z" @default.
- Q66071389 P582 "2020-04-30T00:00:00Z" @default.
- Q66071389 P6099 Q42824827 @default.
- Q66071389 P8363 Q78089383 @default.